Targeting tumor-associated macrophages with anti-CSF-1R antibodies as a strategy for inhibiting T cell lymphoma tumorigenesis

被引:0
|
作者
Hwang, S. [1 ]
Wu, X. [1 ]
Imai, Y. [1 ]
机构
[1] Med Coll Wisconsin, Dermatol, Milwaukee, WI 53226 USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
534
引用
收藏
页码:S92 / S92
页数:1
相关论文
共 50 条
  • [1] Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
    Ries, Carola H.
    Cannarile, Michael A.
    Hoves, Sabine
    Benz, Joerg
    Wartha, Katharina
    Runza, Valeria
    Rey-Giraud, Flora
    Pradel, Leon P.
    Feuerhake, Friedrich
    Klaman, Irina
    Jones, Tobin
    Jucknischke, Ute
    Scheiblich, Stefan
    Kaluza, Klaus
    Gorr, Ingo H.
    Walz, Antje
    Abiraj, Keelara
    Cassier, Philippe A.
    Sica, Antonio
    Gomez-Roca, Carlos
    de Visser, Karin E.
    Italiano, Antoine
    Le Tourneau, Christophe
    Delord, Jean-Pierre
    Levitsky, Hyam
    Blay, Jean-Yves
    Ruettinger, Dominik
    CANCER CELL, 2014, 25 (06) : 846 - 859
  • [2] Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models.
    Li, Yanxia
    Mathew, Sneha
    Wu, Lan
    Wang, Ying
    Persaud, Kris
    Burtrum, Douglas
    Balderes, Paul
    Surguladze, David
    Haurum, John
    Ludwig, Dale
    Doody, Jacqueline
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [3] Anti-CSF-1R antibodies reduce tumor -associated macrophages and inhibit tumor growth in preclinical models
    Doody, Jacqueline
    Mathew, Sneha
    Wu, Lan
    Li, Yanxia
    Wang, Ying
    Persaud, Kris
    Burtrum, Douglas
    Balderes, Paul
    Surguladze, David
    Haurum, John
    Ludwig, Dale
    CANCER RESEARCH, 2012, 72
  • [4] Prosurvival and Chemoprotective Effects of Tumor-Associated Macrophages Reversed By Anti-CSF-1R Monoclonal Antibody in B-Cell Lymphomas
    Gopisetty, Anupama
    Foglietta, Myriam
    Zhang, Min
    Wang, Zhiqiang
    Fowler, Nathan
    Davis, Richard E.
    Neelapu, Sattva S.
    BLOOD, 2014, 124 (21)
  • [5] Potential contribution of tumor-associated slan+ cells as anti-CSF-1R targets in human carcinoma
    Lonardi, Silvia
    Licini, Sara
    Micheletti, Alessandra
    Finotti, Giulia
    Vermi, William
    Cassatella, Marco A.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 103 (03) : 559 - 564
  • [6] Targeting tumor-associated macrophages as an antitumor strategy
    Cheng, Nan
    Bai, Xuexia
    Shu, Yuxin
    Ahmad, Owais
    Shen, Pingping
    BIOCHEMICAL PHARMACOLOGY, 2021, 183
  • [7] CSF-1R Expression in Tumor-Associated Macrophages Is Associated With Worse Prognosis in Classical Hodgkin Lymphoma
    Koh, Young Wha
    Park, Chansik
    Yoon, Dok Hyun
    Suh, Cheotwon
    Huh, Jooryung
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (04) : 573 - 583
  • [8] Reprogramming of tumor-associated macrophages with anti-PD-L1 & lenalidomide in cutaneous T cell lymphoma
    Han, Z.
    Su, C.
    Wu, X.
    Qin, H.
    Gunes, E.
    Rosen, S.
    Querfeld, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S119 - S119
  • [9] Modulating tumor-associated macrophages through CSF1R inhibition: a potential therapeutic strategy for HNSCC
    Chen, Kaiting
    Li, Xiaochen
    Dong, Shuyi
    Guo, Yu
    Luo, Ziyin
    Zhuang, Shi-Min
    Liu, Jie
    Liu, Tianrun
    Liao, Jing
    Wen, Weiping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [10] Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages
    Sato, Takahiko
    Sugiyama, Daisuke
    Koseki, Jun
    Kojima, Yasuhiro
    Hattori, Satomi
    Sone, Kazuki
    Nishinakamura, Hitomi
    Ishikawa, Tomohiro
    Ishikawa, Yuichi
    Kato, Takuma
    Kiyoi, Hitoshi
    Nishikawa, Hiroyoshi
    JCI INSIGHT, 2025, 10 (01)